Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...

Jammu and Kashmir has achieved a record investment of over ₹5,800 crore in 2025-26. This marks a significant jump, thirteen times higher th...

The Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...

Sun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...

The Nifty Pharma index closed 1.0 per cent up at 19774.7.

The Nifty Pharma index closed 1.56 per cent up at 16238.9.

Adani Ent., Adani Ports SEZ, IndusInd Bank, Power Grid and RIL were among the top losers on NSE in today's trade.

Navkar Corp, Gufic BioSci, New India Assurance, LGB Forge and Global Education, hit their fresh 52-week highs during the day.

Gufic said one of the important feature of ‘Zarbot’ is that it has been manufactured using purified HALL strain and proprietary technology ...

The pharmaceutical firm received permission from Central Licensing Approving Authority, Central Drugs Standard Control Organisation (CDSCO)...

The Nifty Pharma index was trading 0.43 per cent down at 13794.15.

The BSE Healthcare index was trading 0.49 per cent up at 13,978 around 12:30 pm.

Buy Gufic BioSciences Ltd. at a price target of Rs 78 and a stoploss at Rs 71.5 from entry point.

Pharma stocks have been showing a volatile trend in the recent times and have remained mostly stock-specific.

Snapping its three day bullish trend, the domestic equity market was trading in red on Thursday.

The company said its board has appointed Gopal Daptari as additional independent director with immediate effect up to the conclusion of the...